Rhythm

Biobeat Expands Access of Wearable Cuffless 24 Hour Ambulatory Blood Pressure Device to Consumers

World’s First BP Cuffless Device – Now Available For Consumers PETAH TIKVA, Israel, Oct. 19, 2021 /PRNewswire/ — Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today that it has made its new wearable and ambulatory blood pressure chest-monitoring device accessible to consumers. Launched in May 2021 for providers, […]

BioSig’s PURE EP System to be Featured in a Live Patient Case During Annual International Symposium on Ventricular Arrhythmias

Company’s signal processing technology for arrhythmia care to be featured during the event co-hosted by the University of Pennsylvania and The Mount Sinai Hospital Westport, CT, Oct. 12, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing […]

AliveCor Launches AliveCor Labs

New National Cardiac Monitoring IDTF Will Offer All Technology Options Including KardiaMobile 6L, The World’s Only Pocket Sized Six-Lead Monitor MOUNTAIN VIEW, Calif., Oct. 12, 2021 /PRNewswire/ — AliveCor, a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of AliveCor Labs, further establishing the company’s footprint in enterprise class clinical workflows. […]

Withings Announces the FDA Clearance of ScanWatch — Its Most Medically Advanced Hybrid Smartwatch

ScanWatch becomes the first wearable device to receive FDA clearance for both atrial fibrillation detection through medical grade ECG and measuring SpO2 levels from the wrist ISSY-LES-MOULINEAUX, France, Oct. 12, 2021 /PRNewswire/ — Today, Withings, pioneers of the connected health revolution, is pleased to announce ScanWatch, its globally acclaimed and most medically advanced wearable, […]

Shockwave IVL Consistently Treats “Real World” Calcium Across Multiple Peripheral Vessel Beds

Disrupt PAD III Observational Arm Confirms IVL Safely and Effectively Modifies Superficial and Deep Calcium in Complex Calcified Lesions SANTA CLARA, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, […]

mSToPS Clinical Trial Demonstrates Zio by iRhythm Significantly Improves Health Outcomes for At-Risk Patient Populations

Data published in PLOS One shows continuous monitoring leads to earlier diagnosis and prevents adverse cardiac events, furthering the case for cardiac screening SAN FRANCISCO, Oct. 05, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, announced the results of […]

Tenax Therapeutics Announces Clearance of the Investigational New Drug Application for Imatinib in Pulmonary Arterial Hypertension (PAH)

Unique, Delayed-Release Formulation of Imatinib Designed to Avoid Gastric Intolerance On Track to Initiate a Single Phase 3 in PAH in 2Q 2022 Recently Updated Company Website Highlights Imatinib Clinical Program MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary […]

Clinical Data Acquired by the PURE EP™ System Published in the Journal of Cardiac Electrophysiology

The PURE EP™ System is validated in multi-center study as superior to conventional sources of intracardiac signals Westport, CT, Oct. 04, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and […]

Continuous Rhythm Monitoring Reveals Strong Short-Term Risk Association Between Atrial Fibrilation Episodes and Ischemic Stroke

Study Published in JAMA Cardiology Demonstrates a Three-Fold Increased Risk of Ischemic Stroke Within 30 Days of a Multi-Hour AF Event DUBLIN, Oct. 4, 2021 /PRNewswire/ — Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the publication of a study demonstrating, through the use of a Medtronic continuous rhythm monitoring […]

Sequana Medical announces FDA approval to expand patient enrolment in North American pivotal alfapump® study (POSEIDON)

Completion of patient enrolment expected before end of year Primary endpoint read-out due in Q4 2022 59 patients already recruited in the Pivotal Cohort Ghent, Belgium – 4 October 2021 – Sequana Medical NV (Euronext Brussels: SEQUA, the “Company”), an innovator in the treatment of diuretic-resistant fluid overload in liver […]